Literature DB >> 837442

Development of methods for the quantitative in vitro analysis of androgen-dependent and autonomous Shionogi carcinoma 115 cells.

E R Stanley, R E Palmer, U Sohn.   

Abstract

Androgen-dependent and androgen-independent (autonomous), cloned, cultured cell lines of the androgen-dependent mouse mammary adenocarcinoma, Shionogi carcinoma 115, have been established. Growth of the dependent cells requires the presence of androgen, provided they are growth in suspension culture in medium containing dextran-charcoal-treated fetal calf serum. The growth rate of autonomous cells in the presence or absence of DHT is similar to that of dependent cells grown in its presence. An agar culture method has been developed that enables the proportion of dependent and autonomous cells in mixed populations to be determined. Autonomous cells appear in dependent clones, and their frequency increases with increasing time of subculture. Dependent cells form tumors preferentially in male animals and dependent cell cytosols contain significant amounts (approximately 300 femtomoles per mg protein) of a specific androgen-binding macromolecule. Autonomous cells formed tumors equally well in both male and female mice, and autonomous cell cytols contain very low levels (less than or equal to 7 femtomoles per mg protein) of the specific androgen-binding macromolecule(s). These studies delineate a system which can be used to investigate the mechanism of steroid hormone-dependent and autonomous tumor growth, and the transitions between the hormone-dependent and autonomous states.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 837442     DOI: 10.1016/0092-8674(77)90137-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  17 in total

1.  Two functional estrogen response elements are located upstream of the major chicken vitellogenin gene.

Authors:  J B Burch; M I Evans; T M Friedman; P J O'Malley
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

2.  Growth and morphology of colonies of Chinese hamster ovary cells growing on agar is affected by insulin.

Authors:  B D Aidells; M W Konrad; D A Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

3.  Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.

Authors:  J Stavenhagen; F Loreni; C Hemenway; M Kalff; D M Robins
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

4.  The alpha-foetoprotein proximal enhancer: localization, cell specificity and modulation by dexamethasone.

Authors:  C Houart; J Szpirer; C Szpirer
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

5.  Steroid-regulated growth of DDT1MF-2 cells is profoundly influenced by culture conditions.

Authors:  D J Lamb; M Ray
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-12       Impact factor: 2.416

6.  Three cell lines showing androgen-dependent, -independent, and -suppressed phenotypes, established from a single tumor of androgen-dependent Shionogi carcinoma 115.

Authors:  T Yamaguchi; K Kawamoto; N Uchida; K Uchida; S Watanabe
Journal:  In Vitro Cell Dev Biol       Date:  1992-04

7.  A complex androgen-responsive enhancer resides 2 kilobases upstream of the mouse Slp gene.

Authors:  F Loreni; J Stavenhagen; M Kalff; D M Robins
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

8.  Dimethyl sulfoxide affects colony morphology on agar and alters distribution of glycosaminoglycans and fibronectin.

Authors:  S H Dairkee; D A Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

9.  Relapse of androgen-dependent tumour of mouse (Shionogi Carcinoma 115) after castration and oestrogen treatment.

Authors:  T Miyauchi; M Wakisaka; S Hara; O Matsuzaki; J Shimazaki
Journal:  Urol Res       Date:  1983

10.  Adjuvant chemo-endocrine therapy for androgen-dependent mammary tumor in mice.

Authors:  N Uchida; K Yamaguchi; N Narita; K Nakao; Y Kitamura; K Matsumoto
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.